Status:
COMPLETED
Modifications to Radical Prostatectomy: Feasibility Study
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Prostate Cancer
Eligibility:
MALE
21+ years
Phase:
NA
Brief Summary
This study aims to determine whether surgeons at Memorial Sloan-Kettering Cancer Center are able to randomize patients to test modifications of surgery to remove the prostate. Surgery to remove the pr...
Eligibility Criteria
Inclusion
- Patients scheduled for radical prostatectomy for the treatment of prostate cancer with one of the consenting surgeons at MSKCC.
Exclusion
- Prior treatment for prostate cancer: radiation, hormonal therapy, chemotherapy or focal therapy.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2018
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT00928850
Start Date
June 1 2009
End Date
May 4 2018
Last Update
November 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065